R. Wendel Naumann

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

David G. Mutch, Mauro Orlando, T. Goss et al. · Journal of Clinical Oncology · 2007 · 441 citations · Full text

Medicine, Oncology, Pharmacology +15

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

R. Wendel Naumann, Antoine Hollebecque, Tim Meyer et al. · Journal of Clinical Oncology · 2019 · 435 citations

Medicine, Oncology, Pharmacotherapy +17

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

R. Wendel Naumann, Robert L. Coleman, Robert A. Burger et al. · Journal of Clinical Oncology · 2013 · 233 citations

Medicine, Oncology, Pharmacology +16

Sexual Dysfunction Following Vulvectomy

Michael Green, R. Wendel Naumann, Mollie Elliot et al. · Gynecologic Oncology · 2000 · 164 citations

Medicine, Gynecology, Surgery +12

Role of Minimally Invasive Surgery in Gynecologic Oncology

Lesley B. Conrad, Pedro T. Ramírez, William M. Burke et al. · International Journal of Gynecological Cancer · 2015 · 142 citations · Full text

Medicine, Oncology, Surgery +17